Understanding Bladder Symptoms from BCG Treatment
Author Information
Author(s): Meera Elmasri, Aaron Clark, Luke Grundy
Primary Institution: Flinders Health and Medical Research Institute (FHMRI), College of Medicine and Public Health, Flinders University, Adelaide, Australia
Hypothesis
What are the mechanisms behind Bacillus Calmette–Guerin (BCG)-induced lower urinary tract symptoms (LUTS)?
Conclusion
BCG immunotherapy can cause significant bladder symptoms that affect patients' quality of life and treatment adherence.
Supporting Evidence
- BCG treatment can lead to lower urinary tract symptoms like urgency and pain.
- Understanding the mechanisms of these symptoms could help improve patient care.
- Inflammation and changes in bladder nerve signaling are likely involved in BCG-induced LUTS.
Takeaway
When patients get a treatment called BCG for bladder cancer, it can make them feel like they need to go to the bathroom a lot or feel pain, which can be really uncomfortable.
Methodology
This review summarizes existing literature and clinical data to explore the mechanisms of BCG-induced LUTS.
Limitations
The review highlights a lack of understanding of the specific mechanisms driving BCG-induced LUTS.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website